Offers guidance on the use of MAT with extended-release injectable naltrexone for the treatment of OUD. Covers assessing patients, initiating MAT, monitoring progress, and deciding when to end treatment.
Source
Substance Abuse and Mental Health Services Administration
File Size
447 KB
Year
Format
Terms of Use
Audience
Resource Type
Special Collection
